海创光电上交所科创板IPO“终止”

Core Viewpoint - Fujian Haichuang Optoelectronics Technology Co., Ltd. (Haichuang Optoelectronics) has had its IPO review status on the Shanghai Stock Exchange's Sci-Tech Innovation Board changed to "terminated" due to the withdrawal of its listing application by the company and its sponsor [1] Company Overview - Haichuang Optoelectronics specializes in laser optical components and laser modules, providing solutions for various laser application systems [1] - The company has established four main business segments: LiDAR, industrial lasers, optical communications, and biomedical applications [1] Clientele - The company has built a strong reputation and a long-term client base across its business segments, including notable clients such as: - LiDAR: Luminar, Tudatong, Suteng Juchuang, Innoviz, Company A, Huace Navigation, Hesai Technology - Industrial Lasers: Raycus Laser, Chuangxin Laser, Jietu Technology, Trumpf, Dazhu Laser, Changguang Huaxin, nLight, Precitec, Hot Stimulus Light - Optical Communications: Coherent, Source Photonics, New Yisheng, Guangxun Technology - Biomedical and Other: Mindray Medical, FISBA, Dimi Bio, MicroPort Medical, BGI, Shanghai Ruike, Optotune, BYK, Company B, Jingce Electronics [2] Financial Performance - The company reported the following revenues and net profits for the years 2022, 2023, and 2024 (in million RMB): - Revenue: 606 million, 833 million, 661 million - Net Profit: 73.62 million, approximately 122 million, 65.34 million [2] Key Financial Metrics - Total assets (in ten thousand RMB) for the years 2022 to 2024: - 2022: 953.11 million - 2023: 1,024.14 million - 2024: 1,058.04 million - Equity attributable to shareholders (in ten thousand RMB): - 2022: 606.27 million - 2023: 733.79 million - 2024: 801.12 million - Debt-to-asset ratio (percentage): - 2022: 36.02% - 2023: 27.77% - 2024: 23.06% [3] Profitability and Efficiency - Net profit (in ten thousand RMB) for the years 2022 to 2024: - 2022: 73.62 million - 2023: 122.26 million - 2024: 65.34 million - Basic and diluted earnings per share (in RMB): - 2022: 1.13 - 2023: 1.88 - 2024: 1.00 - Return on equity (percentage): - 2022: 12.96% - 2023: 18.25% - 2024: 8.51% - Research and development expenditure as a percentage of revenue: - 2022: 7.69% - 2023: 7.38% - 2024: 9.36% [3]